* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Disease name
Middle East respiratory syndrome wikipedia , lookup
Brucellosis wikipedia , lookup
Chagas disease wikipedia , lookup
Schistosomiasis wikipedia , lookup
Bioterrorism wikipedia , lookup
Diagnosis of HIV/AIDS wikipedia , lookup
Leptospirosis wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Creutzfeldt–Jakob disease wikipedia , lookup
OIE Reference Laboratory Reports Activities in 2011 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Address of laboratory: Scrapie and Chronic wasting disease National Reference Laboratory for Scrapie and CWD Ottawa Laboratory (Fallowfield) Canadian Food Inspection Agency 3851 Fallowfield Road Ottawa, Ontario, CANADA K2H 8P9 Tel.: 613-221-4854 Fax: 613-221-6103 e-mail address: website: Name (including Title and Position) of Head of Laboratory (Responsible Official): Name(including Title and Position) of OIE Reference Expert: [email protected] http://www.inspection.gc.ca/english/toce.shtml Karen Jessett Dr Aru Balachandran Veterinary Science Advisor; Head, National and OIE Reference Laboratory for scrapie and CWD Name (including Title and Position) of writer of this report (if different from above): Annual reports of OIE Reference Centres, 2011 1 Scrapie and Chronic wasting disease Part I: Summary of general activities related to the disease 1. Test(s) in use/or available for the specified disease/topic at your laboratory Our laboratory routinely uses a combination of Histopathology, PrP immunohistochemistry and Western blot as confirmatory tests for scrapie and CWD. In addition, rapid screening tests for BSE, CWD (Biorad TeSeE SAPELISA) and scrapie (Biorad TeSeE SAP- ELISA and Biorad TeSeE sheep and goat ELISA) are used for disease control and surveillance testing. Scrapie and CWD confirmed small ruminant and cervid samples are further subjected to VLA discriminatory western blot testing. Confirmation and discrimination bioassays using cervid, and ovine transgenic mice and inbred (VM and RIII) lines of mice are in place. The laboratory also performs the PrP genotyping for scrapie susceptibility/ resistance (codon 136,154 and 171) and elk CWD (codon 132) and white-tailed deer CWD (codon 96). Detecting bovine prohibited materials such as the brain, spinal cord and other neural elements in mechanically separated meat (AMR) products is done routinely using histological and GFAP immunohistochemistry methods. Disease Test For Specifity Total (Diagnosis & Research) Scrapie IHC Antigen PrP Sc 2341 BioRad ELISA Antigen PrP Sc 7662 VLA Hybrid & BioRad TeSeE-Confirm WB Antigen PrP Sc 94 Genotyping sheep Codon136,154,171 IHC Antigen PrP CWD 344 ELISA Antigen PrP CWD 1671 VLA Hybrid & BioRad TeSeE-Confirmatory WB Antigen PrP CWD 189 Genotyping-Elk, whitetailed deer Codon132, 96 BSE ELISA Antigen PrP BSE 5141 AMR IHC Antigen GFAP 418 CWD 2. 5394 152 Production and distribution of diagnostic reagents While most diagnostic reagents required for scrapie and CWD testing are commercially available, we continue to develop and maintain an archive of TSE-positive and negative reference materials for use in test development, validation and proficiency testing programs. These materials are used nationally within our reference and network laboratories and have been provided to countries in North and South America and Asia who are seeking to develop TSE testing programs or validate existing programs. 2 Annual reports of OIE Reference Centres, 2011 Scrapie and Chronic wasting disease Part II: Activities specifically related to the mandate of OIE Reference Laboratories 3. International harmonisation and standardisation of methods for diagnostic testing or the production and testing of vaccines a) Establishment and maintenance of a network with other OIE Reference Laboratories designated for the same pathogen or disease and organisation of regular inter-laboratory proficiency testing to ensure comparability of results A panel of scrapie and CWD-infected and non-infected tissue blocks were provided to the OIE Reference Laboratory for Scrapie in Argentina. b) Organisation of inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results To provide ongoing validation of immunohistochemistry testing as well as maintain ISO 17025 certification, annual proficiency panels consisting of blinded, unstained slides were exchanged with United States Department of Agriculture (USDA) and Colorado State Veterinary laboratories conducting testing for scrapie and CWD. A panel of scrapie infected and non-infected tissue blocks was also provided to a TSE-testing laboratory in Chile. 4. Preparation and supply of international reference standards for diagnostic tests or vaccines We curate an archive of scrapie and CWD-infected reference tissues from sheep, goats and a range of cervid species for use in diagnostic test development and validation. Selected Canadian field cases of confirmed CWD and scrapie have been inoculated into transgenic or inbred mouse strains to provide characterized and standardized infectious reference materials. We utilize several inbred and transgenic strains of mice from international collaborators. These include RIII and VM strains from the Medical Research Council (MRC) in the United Kingdom, Tg338 (ovinized-PrP) mice from the National Institute for Agricultural Research (INRA) in France, cervidized-PrP and humanized-PrP transgenic mice from the National Institutes of Health (NIH) in the United States and bovinized-PrP transgenic mice from the Friedrich-Loeffler-Institut (FLI) in Germany. Quantitative bioassays are conducted to determine infectivity titres of standardized inoculates for test development and validation, as well as for the characterization of Canadian CWD and scrapie strains. 5. Research and development of new procedures for diagnosis and control Evaluation of immuno-PCR for the detection of ultra-low levels of pathologic prion protein: Current testing methods for transmissible spongiform enceophalopathies (TSEs) involve the detection of abnormal prion protein (PrPTSE) by immunochemical methods as the hallmark of infection. Novel technologies that combine higher sensitivity detection with fast, robust, and cost-efficient protocols hold promise for future diagnostic and research applications. Work is in progress to increase the analytical sensitivity of immuno-PCR relative to currently approved test methods and to investigate the applicability for pre-clinical diagnosis and environmental testing. Cervid genotyping for CWD resistance/susceptibility: Susceptibility of cervids to CWD infection has been shown to be associated with polymorphisms in the host prion protein gene. Work is in progress to validate recently developed high throughput methods to detect the allelic variants of elk, white-tailed deer at codons 132, and 96 respectively. This information may be used as a component of regulatory control and eradication programs. Measures of sensitivity and specificity do not apply as per diagnostic testing of a disease/infectious agents since this test provides the genotype of a particular animal and not infected/non-infected status. The method used to detect these allelic variants has undergone partial Level 1 formal validation in accordance with the OIE Validation Template (calibration, repeatability studies). Rodent bioassays for the quantification and characterization of prion infectivity. Studies utilizing our rodent bioassay platform continue for characterising Canadian scrapie and CWD strain variability, investigating species barriers to infectivity and determining infectivity titres from a variety of matrices. Collaborative research projects Annual reports of OIE Reference Centres, 2011 3 Scrapie and Chronic wasting disease are ongoing investigating the utility and validity of novel low-level detection methods such as PMCA and immuno-PCR as well as the reductions of infectivity associated with composting infectious tissues. Research continues towards defining the distribution of infectivity in CWD-infected cervids and if CWD is capable of overcoming a range of species barriers. The rodent bioassay has demonstrated diagnostic utility in discriminating between CWD, atypical and classical scrapie and BSE in diagnostic samples. 6. Collection, analysis and dissemination of epizootiological data relevant to international disease control Enhanced scrapie surveillance is ongoing across Canada with the goal of better understanding the disease prevalence and distribution. This includes continued characterization of all positive cases though IHC, western blot and in some cases bioassay, to discriminate classical scrapie cases from atypical scrapie or potential BSE cases in sheep. Data from this surveillance program will be collated and communicated as it becomes available. The distribution of CWD continues to be monitored in farmed and feral cervid populations with particular interest in detecting expanding geographical ranges and the ability of CWD to infect novel cervid species such as caribou or reindeer. 7. Maintenance of a system of quality assurance, biosafety and biosecurity relevant to the pathogen and the disease concerned The TSE-OIE Reference Laboratory operates within an ISO 17025 accredited facility. Maintenance of this certification requires strict adherence to quality assurance guidelines with an ongoing audit process to ensure the highest standards of testing are sustained. All samples handling and testing is done under strict TSE containment standards in access-restricted laboratories which are subjected to a federally-mandated certification program. 8. Provision of consultant expertise to OIE or to OIE Member Countries Participated in a research collaboration meeting with the Prion Diseases Department of Animal, Plant and Fisheries Quarantine and Inspection Agency, South Korea and gave a presentation on “CWD in North America : An update” Dec 9-12. 9. Provision of scientific and technical training to personnel from other OIE Member Countries Dr Yoon-Hee Lee, Veterinary Researcher from the Animal, Plant and Fisheries Quarantine and Inspection Agency in South Korea visited for 2 weeks (September 12-26) to exchange ideas in diagnostic test methodology and result interpretation in support of a collaborative research project investigating cross-species transmission of CWD. Dr Gabriel Pinto, from the TSE Reference Laboratory, INTA, Buenos Aires, Argentina visited May 21-24 and received training in scrapie and CWD diagnosis. Dr Aline Kawanami from the Department of Veterinary Pathology, FCAV-UNESP, Jaboticabal, Brazil visited September 24-October 03 for training in diagnosis of CWD. 10. Provision of diagnostic testing facilities to other OIE Member Countries Testing for the presence of CWD by immunohistochemistry was undertaken in a small group of samples obtained from wild cervids in Brazil. 11. Organisation of international scientific meetings on behalf of OIE or other international bodies None 4 Annual reports of OIE Reference Centres, 2011 Scrapie and Chronic wasting disease 12. Participation in international scientific collaborative studies A collaborative study with the Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA) in South Korea continues with the objective of characterizing South Korean and Canadian CWD strains. Transmission studies are ongoing in cervid and transgenic mouse models. In August 2011, Dr G. Mitchell travelled to the QIA TSE laboratory to discuss project progress and present an informal seminar to QIA scientists on the transmission of Canadian CWD isolates to transgenic mice. 13. Publication and dissemination of information relevant to the work of OIE (including list of scientific publications, internet publishing activities, presentations at international conferences) Presentations at international conferences and meetings PRION 2011, Montreal, Canada, May 16-19, 2011 Mitchell G, Shaffer P, Foster S, Ghazi D, Rendulich J, Yogasingam N, Hills B, and Balachandran A. Transmission of Canadian CWD Isolates to Transgenic Mice. Gao TT, Tong Y, Wong L, Xiaomei L, Balachandran A, Yogasingam N, Mitchell G, Bowlby E, and Wu J. Thermophilic Anaerobic Digestion Degrades Scrapie Prion Protein and Transforms Specified Risk Materials into Bioenergy. Price LM, Braithwaite S, Balachandran A, Mitchell G, Belosevic M, and Neumann N. Detection of PrPCWD from the Saliva, Urine and Feces of Experimentally-Infected White-Tailed Deer. Harrington N, Rendulich J, and Balachandran A. A review of archived Canadian scrapie cases for evidence of bovine spongiform encephalopathy. University of Guelph Emergency Management Research Expo, Guelph, ON, Canada, Sept. 19, 2011 The RAMALT Procedure to Detect Scrapie in Sheep - Is It Painful? Menzies PI, Haley D, Yates D, Mitchell G and Balachandran A Scientific publications in peer-reviewed journals Huang. H, Soutyrine. A, Rendulich. J, O’Rourke. K, Balachandran. A. Investigation of the effects of experimental autolysis on the detection of abnormal prion protein in lymphoid and central nervous system tissues from elk and sheep using the Western blotting method. Can.J.Vet.Res.2011. Jan. 75(1) 69-72 Blashe.T, Schenck.E.V, Balachandran.A, Miller.M.W, Langenberg.J, Frolich.K, Steibach.F. Rapid detection of CWD PrP: Compariosn of tests designed for the detection of BSE or scrapie. Transbound Emerg Dis. 2011. Dec. doi. 10.1111 ( Epub) _______________ Annual reports of OIE Reference Centres, 2011 5